By Editor , 20 September 2026
QCi Unveils Integrated Quantum Encryption-Authentication Platform at ECOC

Hoboken, N.J. – September 20, 2026 -- Quantum Computing Inc. (Nasdaq: QUBT) will demonstrate, for the first time, a platform combining quantum key distribution (QKD) with hardware-based Quantum Identity Authentication (QIA) on a single system at ECOC Exhibition 2026, running September 21-23 at FYCMA in Málaga, Spain.

By Editor , 20 September 2026

San Antonio – September 20, 2026 -- Frost & Sullivan has named Lenovo a 2026 Global Technology Innovation Leader in AI-powered sports event technology, citing the company's role as FIFA's unified technology partner for the FIFA World Cup 2026TM.

By Editor , 20 September 2026

Geneva – September 20, 2026 -- China's leading hospitals serving international patients recorded 1.28 million international patient visits in 2025, up 73.6% from three years earlier, Dr. John K. Hsiang, Chairman of Jiahui Health's Executive Committee, said at the WTO Public Forum 2026.

By Editor , 20 September 2026
SOCO Launches ODORSORB-101 to Chemically Capture Industrial Odors

Qingdao – September 19, 2026 -- Qingdao SOCO New Material Co., Ltd. has launched ODORSORB-101, a plant-based liquid formulated to chemically capture nitrogen- and sulfur-based odor compounds at industrial and municipal sites rather than mask them.

By Editor , 20 September 2026
Tang Prize Honors CAR-T Pioneers Rosenberg, Sadelain, June in Taipei

Taipei – September 19, 2026 -- The 2026 Tang Prize Award Ceremony convened in Taipei on September 18, honoring six laureates across four categories including three scientists whose work led to FDA-approved CAR T-cell cancer therapies now used worldwide.

By Editor , 20 September 2026
mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A

Madrid – September 19, 2026 -- mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed emicizumab biosimilar targeting hemophilia A, a treatment referencing Roche's Hemlibra with an estimated global reference market of USD 5.7 billion.

By Editor , 20 September 2026

Seoul – September 19, 2026 -- SK hynix Inc. has launched a new corporate venture capital brand, SK hynix Ventures, to expand strategic investments across the global AI ecosystem, the company announced at the inaugural 'SK hynix Ventures Day' held in Silicon Valley.

By Editor , 20 September 2026
Elbit Systems Files Two-Year Shelf Prospectus in Israel

Haifa, Israel – September 19, 2026 -- Elbit Systems Ltd. (NASDAQ: ESLT; TASE: ESLT) has filed a shelf prospectus with the Israel Securities Authority and the Tel Aviv Stock Exchange, opening a two-year window to raise capital through debt and equity offerings in Israel at its own discretion.